Positron emission tomography/computed tomography in melanoma.

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Background:

• Fludeoxyglucose F 18 positron emission tomography/computed tomography (PET/CT) is a key imaging modality in melanoma management.
• Current applications are extensive, but ongoing research seeks to expand its utility.
• Advancements in PET imaging agents are anticipated to enhance diagnostic capabilities.

Purpose of the Study:

• To review the current applications of PET/CT in melanoma.
• To provide practical guidelines for ordering and interpreting PET/CT scans in melanoma patients.
• To highlight potential interpretive pitfalls in PET/CT imaging for melanoma.

Main Methods:

• Review of existing literature on PET/CT in melanoma.
• Discussion of clinical experience and evolving techniques.
• Focus on staging, prognostication, and follow-up applications.

Main Results:

• PET/CT plays a crucial role in assessing melanoma extent and response to therapy.
• Experience with PET/CT continues to grow, refining its diagnostic accuracy.
• Emerging PET agents promise improved detection rates for melanoma.

Conclusions:

• PET/CT is an indispensable tool for comprehensive melanoma patient care.
• Understanding interpretive nuances is essential for accurate diagnosis and management.
• Future developments in PET imaging hold significant promise for advancing melanoma treatment.